Media Coverage

On this podcast episode, Lee Hood and Nathan Price discuss their book, “The Age of Scientific Wellness,” the role of AI in improvising human lifespan, immunotherapy, NMN, gene editing, Alzheimer’s disease, and several other topics.

Using multiomic, blood-based biomarkers, ISB researchers developed signatures of obesity and metabolic disease that can find affected individuals more accurately than body mass index based on height and weight.

Senior Research Scientist Jared Roach discussed complex interactions within biological systems, how we can update the study of biology for the 21st century, how computational and mathematical analysis can help us understand biological systems, and more.

HealthDay interviewed ISB Associate Professor Dr. Sean Gibbons about how gut germs shape a person’s response to food.

This ANI news story highlights research by ISB’s Wei Lab and UC Riverside in how fatty acids are absorbed by single cells, providing new insights into cancer biology.

In this year-in-review roundup, TIME included promising progress made by using CRISPR for treating cancer. ISB President Dr. Jim Heath contributed to this collaborative work. The findings were originally published in the journal Nature.

Seattle Times columnist Naomi Ishisaka spoke with ISB President Dr. Jim Heath about why long COVID is such a hard problem to solve.

In this special report, Scientific American explores how the emerging field of phenomics is merging modern science and technology with ancient and modern ways to keep people healthy to harness health-related data to stop disease before it starts.